NeuBase Therapeutics Gains After Symetryx Acquires 20% Of NBSE Shares
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – NeuBase Therapeutics, Inc. (NBSE) shares are progressing more than 7 percent on Wednesday morning trade after Symetryx Corp announced acquisition of 20 percent of Neubase shares. Symetryx is the largest shareholder of NeuBase.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-611491884-eab74d4b61364ec987b80bff4c516a23.jpg "5 Financial Considerations for Later-in-Life Marriage")
:max_bytes(150000):strip_icc():format(jpeg)/INV_IRACustodian_GettyImages-1473133514-5eceea96894947b0a4f2f8e344696dad.jpg "Retirement Tips: How To Choose the Best IRA Custodian")